Vineet LaboratoriesNSE:VINEETLAB +0.51%47 Return-on-Tangible-Equity is 23.93% as of Dec. 2025, which is 610% above its 10-year median of 3.37. GuruFocus rates NSE:VINEETLAB with a GF Score™ of 47/100 and a GF Value™ of ₹15.33 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,566 Chemicals companies, Vineet Laboratories ranks worse than 95.59% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Vineet Laboratories's annualized net income for the quarter that ended in Dec. 2025 was ₹34.0 Mil. Vineet Laboratories's average shareholder tangible equity for the quarter that ended in Dec. 2025 was ₹142.2 Mil. Therefore, Vineet Laboratories's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 23.93%.
The historical rank and industry rank for Vineet Laboratories's Return-on-Tangible-Equity or its related term are showing as below:
NSE:VINEETLAB'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -81.79 Med: 3.37 Max: 22.19
Current: -51.46
During the past 9 years, Vineet Laboratories's highest Return-on-Tangible-Equity was 22.19%. The lowest was -81.79%. And the median was 3.37%.
NSE:VINEETLAB's Return-on-Tangible-Equity is ranked worse than 95.59% of 1566
companies
in the Chemicals industry
Industry Median: 5.7
vs NSE:VINEETLAB: -51.46
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Vineet Laboratories Return-on-Tangible-Equity Related Terms
Vineet Laboratories Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Vineet Laboratories's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:VINEETLAB vs DOW: Return-on-Tangible-Equity Comparison
For the Chemicals subindustry, Vineet Laboratories's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vineet Laboratories Return-on-Tangible-Equity vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Vineet Laboratories's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Vineet Laboratories's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 23.93% mean?
Vineet Laboratories (NSE:VINEETLAB) has a Return-on-Tangible-Equity of 23.93% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Vineet Laboratories and its competitors. This is 610% above median its historical median of 3.37. According to the industry distribution chart, Vineet Laboratories ranks #1497 out of 1566 companies in the Chemicals industry, placing it in the top 95.6%.
Is Vineet Laboratories' Return-on-Tangible-Equity too high?
Vineet Laboratories' current Return-on-Tangible-Equity of 23.93% is 610% above median its 10-year median of 3.37. The Chemicals industry median Return-on-Tangible-Equity is 5.70. Vineet Laboratories' value of 23.93% is 319.8% above this industry median. Based on the distribution chart, Vineet Laboratories ranks #1497 out of 1566 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Vineet Laboratories has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vineet Laboratories' Return-on-Tangible-Equity compare to DOW?
According to the Chemicals industry distribution chart, Vineet Laboratories ranks #1497 out of 1566 companies for Return-on-Tangible-Equity. This places Vineet Laboratories in the lower half of its industry. The industry median Return-on-Tangible-Equity is 5.70. Vineet Laboratories' value of 23.93% is 319.8% above this benchmark. While the company's 10-year median is 3.37 vs. the industry median of 5.70, Vineet Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Chemicals company?
The median Return-on-Tangible-Equity among Chemicals companies is 5.70, based on 1,566 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vineet Laboratories's current Return-on-Tangible-Equity of 23.93% is 319.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Vineet Laboratories and its competitors. For the Chemicals industry, the median Return-on-Tangible-Equity is 5.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vineet Laboratories's current Return-on-Tangible-Equity is 23.93%, which is 610% above median its own 10-year median of 3.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vineet Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vineet Laboratories (NSE:VINEETLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹15.33, compared to a current price of ₹33.48 — trading 118.4% above its estimated fair value. The current Return-on-Tangible-Equity is 23.93%, which is 610% above median its 10-year median of 3.37 and 319.8% above the Chemicals industry median of 5.70. Vineet Laboratories' overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Vineet Laboratories (NSE:VINEETLAB), the current Return-on-Tangible-Equity is 23.93% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vineet Laboratories (NSE:VINEETLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Vineet Laboratories stock appears to be overvalued.
The current stock price of ₹33.48 is trading 118.4% above its estimated GF Value™ of ₹15.33.
GuruFocus considers Vineet Laboratories to be Significantly Overvalued.
Key valuation signals for NSE:VINEETLAB:
Return-on-Tangible-Equity: 23.93% (610% above median its 10-year median of 3.37)
GF Value™: ₹15.33 vs. price of ₹33.48 (118.4% above fair value)
Industry Position: 319.8% above the Chemicals median (#1497 of 1566)
No single metric tells the full story. See the NSE:VINEETLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vineet Laboratories Ltd is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Nitrophenyl phosphate disodium salt, and others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, the manufacture of Drug Intermediates & Bulk Dugs.
47GF Score
Get the complete analysis for NSE:VINEETLAB
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VINEETLAB has been successfully added to your 
